Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study

被引：32

作者：

Chen W. ^{[1
]}

Dang Y. ^{[1
]}

Zhu C. ^{[1
]}

机构：

[1] Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College

来源：

Chinese Medicine | / 5卷 / 1期

基金：

中国国家自然科学基金;

关键词：

Pharmacokinetic Study; Saponin; Ginsenoside; Quality Control Sample; Glipizide;

D O I：

10.1186/1749-8546-5-12

中图分类号：

学科分类号：

摘要：

Background: Panax notoginseng saponins (PNS), the main active components of Radix Notoginseng, has been used for treating atherosclerosis, cerebral infarction, and cerebral ischemia. Ginsenosides Rg1, ginsenoside Rb1, and notoginsenoside R1 are the main contributors of biological activities, determination of these three saponins is very important for the in vivo evaluation of PNS. The present study aims to develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous quantification of ginsenosides Rg1, ginsenoside Rb1, and notoginsenoside R1. The use of this method was exemplified in pharmacokinetic study of beagle dog plasma after oral administration of PNS.Methods: Liquid chromatography-tandem mass spectrometry (LC/MS/MS) method was combined with solid-phase extraction (SPE). This setup was used to determine simultaneously the three major PNS (ginsenoside Rg1, ginsenoside Rb1, and notoginsenoside R1) in beagle dog plasma. Tandem mass spectrometry was performed using electrospray ionization in the positive ion mode.Results: The lower limits of quantification were 0.5 ng/mL for notoginsenoside R1, 0.82 ng/mL for ginsenoside Rg1, and 1.10 ng/mL for ginsenoside Rb1. The calibration curves for the three saponins were linear over the concentration ranges 2.64-264 ng/mL (r2 = 0.9967, P = 0.003), 3.6-360 ng/mL (r2 = 0.9941, P = 0.004), and 18.7-1870 ng/mL (r2 = 0.9912, P = 0.004) for notoginsenoside R1, ginsenoside Rg1, and ginsenoside Rb1, respectively. Within these concentration ranges, the relative standard deviation (RSD) of intra- and interday assays for the three PNS from beagle dog plasma samples were less than 12%.Conclusions: This LC/MS/MS method in combination with SPE is useful in the pharmacokinetic study of PNS, such as the simultaneous determination of saponins in beagle dog plasma after oral administration. © 2010 Chen et al; licensee BioMed Central Ltd.

引用

共 20 条

[1]

Gan F.Y., Zheng G.Z., Review of study on chemical constituent of Panax notoginseng, Chin Pharm J, 2, pp. 138-142, (1992)

[2]

Wang N., Wan J.B., Li M.Y., Wang Y.T., Advances in studies on Panax notoginseng against atherosclerosis, Chin Tradit Herb Drugs, 5, pp. 787-791, (2008)

[3]

Yao X.H., Li X.J., Panax notoginseng saporins injection in treatment of cerebral infarction with a multicenter study, Chin J New Drugs Clin Rem, 20, pp. 257-260, (2001)

[4]

Yao X.H., Li X.J., Protective effects and its mechanism of panaxatriol saponins isolated from Panax notoginseng on cerebral ischemia, Zhongguo Zhong Yao Za Zhi, 27, 5, pp. 371-373, (2002)

[5]

Ma W.G., Mizutani M., Malterud K.E., Lu S.L., Ducrey B., Tahara S., Saponins from the roots of Panax notoginseng, Phytochemistry, 52, 6, pp. 1133-1139, (1999)

[6]

Hen S.-W., Wang Y., Wang Y., Wang J., Zhong-Me H.E., Wang B.-X., Study on Anti-Tumor Activity of Ginsenoside Rg1 and Rh1, Journal of Jilin university (Medicine Edition), 29, 1, pp. 25-28, (2003)

[7]

Odani T., Tanizawa H., Takino Y., Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat, Chem Pharm Bull, 31, 1, pp. 292-298, (1983)

[8]

Odani T., Tanizawa H., Takino Y., Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. β. The absorption, distribution and excretion of ginsenoside Rg1 in the rat, Chem Pharm Bull, 31, 3, pp. 1059-1066, (1983)

[9]

Hasegawa H., Sung J.H., Matsumiya S., Uchiyama M., Main ginseng saponin metabolites formed by intestinal bacteria, Planta Med, 62, 5, pp. 453-457, (1996)

[10]

Xu Q.F., Fang X.L., Chen D.F., Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats, J Ethnopharmacol, 84, 2-3, pp. 187-192, (2003)

← 1 2 →